SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-23-004947
Filing Date
2023-08-03
Accepted
2023-08-03 08:01:53
Documents
62
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cmpx20230630_10q.htm   iXBRL 10-Q 861495
2 EXHIBIT 31.1 ex_547758.htm EX-31.1 14062
3 EXHIBIT 31.2 ex_547759.htm EX-31.2 14065
4 EXHIBIT 32.1 ex_547760.htm EX-32.1 5591
5 EXHIBIT 32.2 ex_547761.htm EX-32.2 5611
  Complete submission text file 0001171843-23-004947.txt   4503241

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cmpx-20230630.xsd EX-101.SCH 41803
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cmpx-20230630_cal.xml EX-101.CAL 34882
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cmpx-20230630_def.xml EX-101.DEF 263241
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmpx-20230630_lab.xml EX-101.LAB 241249
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmpx-20230630_pre.xml EX-101.PRE 293349
56 EXTRACTED XBRL INSTANCE DOCUMENT cmpx20230630_10q_htm.xml XML 741052
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39696 | Film No.: 231138159
SIC: 2836 Biological Products, (No Diagnostic Substances)